What is Ocular Therapeutix's gross profit?

Ocular Therapeutix (OCUL) reported gross profit of $9.46M in Q1 2026.

How has Ocular Therapeutix's gross profit changed year-over-year?

Ocular Therapeutix's gross profit increased by 0.2% year-over-year, from $9.44M to $9.46M.

What is the long-term trend for Ocular Therapeutix's gross profit?

Over 4 years (2021 to 2025), Ocular Therapeutix's gross profit has grown at a 3.8% compound annual growth rate (CAGR), from $39.12M to $45.38M.

What does gross profit mean?

Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Ocular Therapeutix OCUL Gross Profit

Gross Profit at other companies

Tarsus Pharmaceuticals, Inc.TARS

$152.66M+109%

PBH

Prestige Consumer HealthcarePBH

$146.3M-13.9%

Arcutis Biotherapeutics, Inc.ARQT

$95.61M+67.7%

LQD

Liquidia CorporationLQDA

$1.6M+6.5%

GlaukosGKOS

$117.23M+42.4%

Axsome TherapeuticsAXSM

——

Other financials

Income statement

See full

Revenue$10.8M+0.8%

Operating income-$93.3M-46.0%

Net income-$88.6M-38.3%

EPS (diluted)-$0.40-5.3%

Balance sheet

See full

Cash & equivalents$666.7M+90.7%

Total debt$79.5M+4.2%

Total equity$581.6M+119%

Total assets$732.5M+80.5%

Cash flow

See full

Operating cash flow-$66.0M-47.7%

CapEx$4.7M+141%

Free cash flow-$70.7M-51.6%

Valuation

See full

Market cap$2.21B+58.2%

Enterprise value$1.63B+40.8%

P/S42.6×+19.1×

Profitability

See full

Gross margin87.2%-3.4pp

Operating margin-575.4%+1,233pp

Net margin-558.2%+1,493pp

FCF margin-463%+2,860pp

Returns & leverage

See full

Return on equity-68.6%+17.0pp

Debt / equity0.1×-0.2×

Current ratio14.8×+4.6×

Where this comes from

Calculated from Ocular Therapeutix’s reported figures.

$10.8Mtotal revenue−$1.3Mtotal cost of revenue=$9.46M

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ocular Therapeutix's gross profit?: Ocular Therapeutix (OCUL) reported gross profit of $9.46M in Q1 2026.
How has Ocular Therapeutix's gross profit changed year-over-year?: Ocular Therapeutix's gross profit increased by 0.2% year-over-year, from $9.44M to $9.46M.
What is the long-term trend for Ocular Therapeutix's gross profit?: Over 4 years (2021 to 2025), Ocular Therapeutix's gross profit has grown at a 3.8% compound annual growth rate (CAGR), from $39.12M to $45.38M.
What does gross profit mean?: Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.